Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva's $15B free drug opioid settlement might be a great deal in the long run: analyst | Fierce Pharma
Tags search | Ctech
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - BNN Bloomberg
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
New York jury holds drug firm Teva liable in opioid crisis
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva considering cutting up to 10,000 jobs: Bloomberg | Reuters
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
The Adderall supply squeeze in the US is growing
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Wins UK Challenge Over Key Novartis Drug Patents (1)
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
